USPTO 2015–2025 USPTO PatentsView US Corporation

VentureMed Group, Inc.

USPTO PatentsView assignee record - 15 granted patents across 2 technology areas, recorded in grant years 2021–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

RSS updates for this company

The verdict

According to USPTO PatentsView, Venturemed ranks #19,322 of 49,997 tracked US assignees by granted-patent volume, with 15 patents across 2 technology areas.

#19,322
of 49,997 US assignees by volume
Top 30%
by Innovation Score (42.8/100)
17.5
avg claims per patent

USPTO PatentsView assignee plate

Corpus R19322 · US Corporation #19,322 · 15 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · SPAN-YRS · BOOK-RICH

  • GRANTS-MICRO 15 grants
  • MID-PACK #19,322/49,997
  • PHOTO-FINISH Valve Medical
  • CPC-NARROW A61B · 2 areas
  • INNOV-PAR 42.8/100
  • CLAIMS-RICH 17.5 claims/avg
  • TYPE-USCORP US Corporation
  • SPAN-YRS 2021–2025 · 5y
  • BOOK-RICH 9/10 fields

Nearest grant-volume peer: Valve Medical Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Venturemed’s 42.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Venturemed

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Venturemed's Innovation Score is 42.8/100 (top 30% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Venturemed?

Each dot is one of Venturemed’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Venturemed’s own 17.5 claims/patent is ABOVE the 16.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Venturemed vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 14.914.91515.1 051015202530 Granted patents (volume) Avg claims / patent Valve Medical Ltd. - 15, 23.73Valve MedicalVascular Imaging Corporation - 15, 15.07Vascular ImagingVaxxas Pty Limited - 15, 16.53Vaxxas PtyVedanta Biosciences, Inc. - 15, 15.47Vedanta Bioscienc…Veritone Alpha, Inc. - 15, 25.53Veritone AlphaVerona Pharma PLC - 15, 17.27Verona PharmaVi-Jon, LLC - 15, 5.93Vi-jonVicarious FPC, Inc. - 15, 18.8Vicarious FPCVentureMed Group, Inc. - 15, 17.47Venturemed Group
Venturemed vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Venturemed's grants concentrate

VentureMed Group, Inc. is a focused PatentsView assignee: 2 CPC subclasses with 100% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2023 (4 grants) versus a trough of 1 in 2024. By volume, Venturemed sits between Valve Medical Ltd. and Vicarious FPC, Inc..

Venturemed's three-year grant acceleration

VentureMed Group, Inc. shows 8 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at VentureMed's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows VentureMed holds 15 patents at rank #19,323, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near VentureMed

By rank, the assignees closest to #19,323 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in VentureMed's primary technology class.

Venturemed's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

43 Top 30% higher than 70% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

012345 20212022202320242025 4
USPTO utility patent grants by year · 2021–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.

View data table
VentureMed Group, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2021 3 20.0%
2022 3 20.0%
2023 4 26.7%
2024 1 6.7%
2025partial year 4 26.7%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

VentureMed Group, Inc.'s patent record in context - here's where to go next.

  • VentureMed Group, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 100% of its portfolio - see every assignee active in that class. Explore A61B
  • Ranked #19,322 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare VentureMed Group, Inc. against Valve Medical Ltd., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 42.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.